Consistent with the correlation of miR-100 with EMT markers (Figure 1F and 1G), the luminal A subtype of primary breast tumors (which are known to be E-cadherin-positive and vimentin-negative) exhibited the most significant downregulation of miR-100 (Figure 2A). This evidence concerns the gene CDH1 and breast neoplasm.